SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-082709
Filing Date
2024-04-01
Accepted
2024-04-01 08:05:53
Documents
13
Period of Report
2024-04-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d819425d8k.htm   iXBRL 8-K 34708
  Complete submission text file 0001193125-24-082709.txt   158689

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eq-20240401.xsd EX-101.SCH 2846
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20240401_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20240401_pre.xml EX-101.PRE 11260
17 EXTRACTED XBRL INSTANCE DOCUMENT d819425d8k_htm.xml XML 3668
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 24805639
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)